Royal Bank of Canada
EDVA

Royal Bank of Canada’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Royal Bank of Canada’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed – – 7366
2024
Q2 		$0 Buy
2
+1
+100% +$47 ﹤0.01% 7473
2024
Q1 		$0 Sell
1
-1
-50% -$80 ﹤0.01% 7519
2023
Q4 		$0 Buy
2
+1
+100% +$95 ﹤0.01% 7522
2023
Q3 		$0 Sell
1
-2
-67% -$259 ﹤0.01% 7515
2023
Q2 		$0 Sell
3
-16
-84% -$2.92K ﹤0.01% 7611
2023
Q1 		$5K Buy
+19
New +$3.77K ﹤0.01% 6581
2022
Q4 		– Sell
-1
Closed – – 7648
2022
Q3 		$0 Buy
+1
New +$379 ﹤0.01% 7795
2022
Q2 		– Sell
-6
Closed -$3K – 7671
2022
Q1 		$3K Buy
+6
New +$3.06K ﹤0.01% 7396

Other funds holding EDVA

CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
SCTC
Sanibel Captiva Trust Company Sanibel, Florida $4.02B AUM 34.36% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Royal Bank of Canada's EDVA Position: Q3 2024 in Review

Royal Bank of Canada sold out of Endovia Health Sciences, Inc. (EDVA) in Q3 2024, closing a stake of 2 shares.

Royal Bank of Canada first reported a position in EDVA in Q1 2022 and held it in 8 quarters. The position peaked at $5K in Q1 2023. 30 funds tracked by Wall St. Rank hold EDVA as of Q3 2024.

  • Royal Bank of Canada reported no remaining Endovia Health Sciences, Inc. position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 2 Endovia Health Sciences, Inc. shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Endovia Health Sciences, Inc. in Q1 2022 and held it in 8 quarters.
  • Royal Bank of Canada's Endovia Health Sciences, Inc. position peaked at $5K in Q1 2023.
  • 30 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.